IDO1 and acute myeloid leukemia: Therefore, IDO inhibition, with a focus on the use of new IDO inhibitors along with chemotherapy, can be an acceptable solution to overcome immune escape mechanisms in patients with AML, who experience increased levels of IDO expression.